BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kong Y, Ai C, Dong F, Xia X, Zhao X, Yang C, Kang C, Zhou Y, Zhao Q, Sun X, Wu X. Targeting of BMI-1 with PTC-209 inhibits glioblastoma development. Cell Cycle 2018;17:1199-211. [PMID: 29886801 DOI: 10.1080/15384101.2018.1469872] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Akita N, Okada R, Mukae K, Sugino RP, Takenobu H, Chikaraishi K, Ochiai H, Yamaguchi Y, Ohira M, Koseki H, Kamijo T. Polycomb group protein BMI1 protects neuroblastoma cells against DNA damage-induced apoptotic cell death. Exp Cell Res 2023;422:113412. [PMID: 36370852 DOI: 10.1016/j.yexcr.2022.113412] [Reference Citation Analysis]
2 Zhu C, Wang X, Wang Y, Wang K. Functions and underlying mechanisms of lncRNA HOTAIR in cancer chemotherapy resistance. Cell Death Discov 2022;8:383. [PMID: 36100611 DOI: 10.1038/s41420-022-01174-3] [Reference Citation Analysis]
3 Lv X, Li Q, Liu H, Gong M, Zhao Y, Hu J, Wu F, Wu X. JUN activation modulates chromatin accessibility to drive TNFα ‐induced mesenchymal transition in glioblastoma. J Cellular Molecular Medi. [DOI: 10.1111/jcmm.17490] [Reference Citation Analysis]
4 Huang J, Chen S, Lin C. Targeting Cancer Stem Cells through Epigenetic Modulation of Interferon Response. JPM 2022;12:556. [DOI: 10.3390/jpm12040556] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Di Pietro A, Polmear J, Cooper L, Damelang T, Hussain T, Hailes L, O'Donnell K, Udupa V, Mi T, Preston S, Shtewe A, Hershberg U, Turner SJ, La Gruta NL, Chung AW, Tarlinton DM, Scharer CD, Good-Jacobson KL. Targeting BMI-1 in B cells restores effective humoral immune responses and controls chronic viral infection. Nat Immunol 2022;23:86-98. [PMID: 34845392 DOI: 10.1038/s41590-021-01077-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
6 Xue YY, Lu YY, Sun GQ, Fang F, Ji YQ, Tang HF, Qiu PC, Cheng G. CN-3 increases TMZ sensitivity and induces ROS-dependent apoptosis and autophagy in TMZ-resistance glioblastoma. J Biochem Mol Toxicol 2021;:e22973. [PMID: 34967073 DOI: 10.1002/jbt.22973] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Martins WK, Silva MDND, Pandey K, Maejima I, Ramalho E, Olivon VC, Diniz SN, Grasso D. Autophagy-targeted therapy to modulate age-related diseases: Success, pitfalls, and new directions. Curr Res Pharmacol Drug Discov 2021;2:100033. [PMID: 34909664 DOI: 10.1016/j.crphar.2021.100033] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
8 Zhang K, Xu J, Ding Y, Shen C, Lin M, Dai X, Zhou H, Huang X, Xue B, Zheng B. BMI1 promotes spermatogonia proliferation through epigenetic repression of Ptprm. Biochem Biophys Res Commun 2021;583:169-77. [PMID: 34739857 DOI: 10.1016/j.bbrc.2021.10.074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Freire-Benéitez V, Pomella N, Millner TO, Dumas AA, Niklison-Chirou MV, Maniati E, Wang J, Rajeeve V, Cutillas P, Marino S. Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. NAR Cancer 2021;3:zcab009. [PMID: 34316702 DOI: 10.1093/narcan/zcab009] [Reference Citation Analysis]
10 Zhou W, Yun Z, Wang T, Li C, Zhang J. BTF3-mediated regulation of BMI1 promotes colorectal cancer through influencing epithelial-mesenchymal transition and stem cell-like traits. Int J Biol Macromol 2021;187:800-10. [PMID: 34293363 DOI: 10.1016/j.ijbiomac.2021.07.106] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 Zhao X, Wu X. Polycomb-group proteins in the initiation and progression of cancer. J Genet Genomics 2021;48:433-43. [PMID: 34266781 DOI: 10.1016/j.jgg.2021.03.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
12 Muselli F, Mourgues L, Morcos R, Rochet N, Nebout M, Guerci-Bresler A, Faller DV, William RM, Mhaidly R, Verhoeyen E, Legros L, Peyron JF, Mary D. Combination of PKCδ Inhibition with Conventional TKI Treatment to Target CML Models. Cancers (Basel) 2021;13:1693. [PMID: 33918475 DOI: 10.3390/cancers13071693] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Poonaki E, Ariakia F, Jalili-nik M, Shafiee Ardestani M, Tondro G, Samini F, Ghasemi S, Sahab-negah S, Gorji A. Targeting BMI-1 with PLGA–PEG nanoparticle-containing PTC209 modulates the behavior of human glioblastoma stem cells and cancer cells. Cancer Nano 2021;12. [DOI: 10.1186/s12645-021-00078-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Kunadis E, Lakiotaki E, Korkolopoulou P, Piperi C. Targeting post-translational histone modifying enzymes in glioblastoma. Pharmacol Ther 2021;220:107721. [PMID: 33144118 DOI: 10.1016/j.pharmthera.2020.107721] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
15 Forgione MO, McClure BJ, Yeung DT, Eadie LN, White DL. MLLT10 rearranged acute leukemia: Incidence, prognosis, and possible therapeutic strategies. Genes Chromosomes Cancer 2020. [PMID: 32720323 DOI: 10.1002/gcc.22887] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
16 Gao T, Lin M, Shao B, Zhou Q, Wang Y, Chen X, Zhao D, Dai X, Shen C, Cheng H, Yang S, Li H, Zheng B, Zhong X, Yu J, Chen L, Huang X. BMI1 promotes steroidogenesis through maintaining redox homeostasis in mouse MLTC-1 and primary Leydig cells. Cell Cycle 2020;19:1884-98. [PMID: 32594840 DOI: 10.1080/15384101.2020.1779471] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
17 Felker J, Broniscer A. Improving long-term survival in diffuse intrinsic pontine glioma. Expert Rev Neurother 2020;20:647-58. [PMID: 32543245 DOI: 10.1080/14737175.2020.1775584] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Yan R, Cui F, Dong L, Liu Y, Chen X, Fan R. Repression of PCGF1 Decreases the Proliferation of Glioblastoma Cells in Association with Inactivation of c-Myc Signaling Pathway. Onco Targets Ther 2020;13:253-61. [PMID: 32021272 DOI: 10.2147/OTT.S234517] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
19 Sulaiman S, Arafat K, Iratni R, Attoub S. PTC-209 Anti-Cancer Effects Involved the Inhibition of STAT3 Phosphorylation. Front Pharmacol 2019;10:1199. [PMID: 31695609 DOI: 10.3389/fphar.2019.01199] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
20 Vora P, Seyfrid M, Venugopal C, Qazi MA, Salim S, Isserlin R, Subapanditha M, O’farrell E, Mahendram S, Singh M, Bakhshinyan D, Chokshi C, Mcfarlane N, Dvorkin-gheva A, Brown KR, Murty N, Moffat J, Bader GD, Singh SK. Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells. J Neurooncol 2019;143:417-28. [DOI: 10.1007/s11060-019-03192-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
21 Cacabelos R. Epigenetics and Pharmacoepigenetics of Neurodevelopmental and Neuropsychiatric Disorders. Pharmacoepigenetics. Elsevier; 2019. pp. 609-709. [DOI: 10.1016/b978-0-12-813939-4.00022-x] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]